0001841613-21-000003.txt : 20210302 0001841613-21-000003.hdr.sgml : 20210302 20210301213516 ACCESSION NUMBER: 0001841613-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210301 EFFECTIVENESS DATE: 20210302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vividion Therapeutics, Inc. CENTRAL INDEX KEY: 0001671687 IRS NUMBER: 464373293 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390895 FILM NUMBER: 21701002 BUSINESS ADDRESS: STREET 1: 5820 NANCY RIDGE DR. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 345-4690 MAIL ADDRESS: STREET 1: 5820 NANCY RIDGE DR. CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001671687 Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. SAN DIEGO CA CALIFORNIA 92121 (858) 345-4690 DELAWARE Cardinal LS, Inc. None Corporation true Jeffrey Hatfield c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Executive Officer Director Patricia L. Allen c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Executive Officer Benjamin Cravatt c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Director Kristina Burow c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Director John Clarke c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Director Richard Heyman c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Director Thomas E. Daniel c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Director Thomas Woiwode c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Director Jakob Loven c/o Vividion Therapeutics, Inc. 5820 NANCY RIDGE DR. San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2021-02-18 false true false 0 135000015 135000015 0 false 27 0 0 0 false Vividion Therapeutics, Inc. /s/ Jeffrey Hatfield Jeffrey Hatfield Chief Executive Officer 2021-03-01